Compounds > losartan
Page last updated: 2024-10-30

losartan and Dysphagia

losartan has been researched along with Dysphagia in 2 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arai, T2
Yasuda, Y2
Takaya, T2
Toshima, S2
Kashiki, Y2
Yoshimii, N1
Fujiwara, H2
Yoshimi, N1

Trials

2 trials available for losartan and Dysphagia

ArticleYear
Angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists, and symptomless dysphagia.
    Chest, 2000, Volume: 117, Issue:6

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents;

2000
Angiotensin II receptor antagonists cannot prevent symptomless dysphagia in hypertensive bedridden older patients with stroke.
    Journal of the American Geriatrics Society, 2000, Volume: 48, Issue:12

    Topics: Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Antihypertensive Agents; Bed Rest; Case-C

2000